Development of Magnetic Resonance (MR) Simulation for Treatment Planning

Retrospectively have access to MR images of patients to develop software that:

1. segment images 2. convert MR values to electron density and then 3. entered into a dose calculation system

The project involves software development of data that is already available. No intervention is made at this point.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Cross Cancer Institute

Edmonton, Alberta, T6G 1Z2, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subject 18 years of age and older

Sponsors and collaborators

Lead sponsor

AHS Cancer Control Alberta

Other

Collaborators

Cross Cancer Institute

Registry information

Official study title

Development of MR Simulation for Treatment Planning

Important dates

Study start: 2005
Primary completion: 2009
Study completion: 2009
First posted: Apr 14, 2006
Registry last updated: Feb 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed